Abstract: Described herein are C60/70/PS-CB-Abx and nano-C60/70PS compounds, their pharmaceutical compositions, and methods pf photodynamic therapy using the compounds and compositions.

Abstract: The invention relates to fullerene compounds of the following formula: in which X1, X2, X3, X4, X5, Y1, Y2, V, W, F, E, R, r, n, p, and q are defined as in the specification. Also disclosed are pharmaceutical compositions containing one of the compounds described above.

Abstract: An E-isomeric fulleropyrrolidine compound of formula (I): is disclosed. Also disclosed is a method for preparing and polymers prepared from such a compound.

Abstract: An E-isomeric fulleropyrrolidine compound of formula (I): is disclosed. Also disclosed is a method for preparing and polymers prepared from such a compound.

Abstract: An E-isomeric fulleropyrrolidine compound of formula (I): 1

Abstract: An E-isomeric fulleropyrrolidine compound of formula (I): is disclosed. Also disclosed is a method for preparing and polymers prepared from such a compound.

Abstract: An E-isomeric fulleropyrrolidine compound of formula (I): 1

Abstract: An E-isomeric fulleropyrrolidine compound of formula (I): 1

Abstract: A method of inhibiting the growth of tumor cells in a tumor site of a subject. The method includes administering to the tumor site an oligoaniline and subsequently exposing the tumor site to irradiation.

Abstract: An E-isomeric fulleropyrrolidine compound of formula (I): is disclosed. Also disclosed is a method for preparing and polymers prepared from such a compound.

Abstract: A compound, of the following formula: Also disclosed is a pharmaceutical composition containing a pharmaceutically effective amount of the compound.

Abstract: Disclosed herein are fullerene derivatives of the formula, F(—E)n(—R1)p(—R2)q, in which F is a fullerene core; E is a nucleophilic substituent; R1 is an amino group or a hydroxyl group; R2 is an epoxide group and n is 1-30; p is 1-20; and q is 0-10. Also disclosed is a method of preparing such derivatives using polynitrofullerenes or polycyclosulfated fullerenes as intermediates.

Abstract: Polyorganofullerene and polyhydroxyorganofullerene derivatives have the respective formulas, F--(E).sub.n and F--(E).sub.n --(OH).sub.m, in which F is a fullerene core; E is a nucleophilic substituent; --OH is a hydroxy group; n is 2-30; and m is 1-20. Also disclosed is a method of preparing such polyorgano-fullerene and polyhydroxyorganofullerene derivatives using polynitrofullerenes or polycyclosulfated fullerenes as intermediates.

Abstract: The present invention relates to a novel fullerene-derived metallocene. Such fullerene-derived metallocene can be used as the catalyst for preparing olefin polymers.

Abstract: Polyorganofullerene and polyhydroxyorganofullerene derivatives have the respective formulas, F--(E).sub.n and F--(E).sub.n -- (OH).sub.m, in which F is a fullerene core; E is a nucleophilic substituent; --OH is a hydroxy group; n is 2-30; and m is 1-20. Also disclosed is a method of preparing such polyorgano-fullerene and polyhydroxyorganofullerene derivatives using polynitrofullerenes or polycyclosulfated fullerenes as intermediates.

Abstract: The present invention relates to a novel fullerene-containing metallocene. Such a fullerene-containing metallocene can be used as the catalyst for preparing olefin polymers.

Abstract: A method of treating a free radical-related medical condition. The method includes the step of administering to a subject in need of such treatment an effective amount of a compound of the formulaF(--X).sub.mwhereinF is a fullerene core; each X is independently OH, (CH.sub.2).sub.n --SO.sub.3 H, or a metal salt of (CH.sub.2).sub.n --SO.sub.3.sup.- in which each n is independently 2-50; and m is 2-40.

Abstract: The invention relates to fullerene derivatives which are capable of scavenging free radicals. The derivatives have the formula F(--X).sub.m (--Y--Z).sub.n, in which F is a fullerene core; each X is independently --CO.sub.2.sup.-, --SO.sub.3.sup.-, --SH, or the like; each --Y--Z is independently (C.sub.3-30 alkyl ether).sub.50 --CH.sub.2 --CO.sub.2.sup.-, (C.sub.3-30 alkyl ester).sub.50 --CH.sub.2 --SO.sub.3.sup.-, (C.sub.3-30 alkyl amide).sub.50 --CH.sub.2 --SH, or the like; m is 0-30; n is 0-30; and the sum of m and n is 2-30.

Abstract: The present invention relates to a polymer including a fullerene core and a plurality of prepolymer units. Each of the prepolymer units is linked to a carbon atom of the core by a moiety independently selected from the group consisting of --O--(C.dbd.O)--NH--, --NH--(C.dbd.O)--NH--, --0--(C.dbd.S)--NH--, and --N--(C.dbd.S)--NH--.

Abstract: One embodiment of the present invention is directed to polysubstituted fullerene moieties having a plurality of substituents thereon, selected from the group consisting of hydroxy, oxide, nitro, amino, organocarboxy, amide, and mixtures thereof.Another embodiment is directed toward the preparation of the novel polysubstituted fullerenes. The method of forming polysubstituted fullerenes comprises contacting fullerenes with an electrophilic reagent such as nitronium ion or an organic peracid. When the electrophilic agent is nitronium ion, the fullerene is further contacted with a nucleophilic reagent. Polysubstituted fullerenes comprise a fullerene moiety selected from fullerenes or mixtures thereof having a plurality of substituents thereon.The polysubstituted fullerenes are particularly useful as cross-linking agents in polymers and/or as core building blocks of star polymers.